Bioceres Crop Solutions (BIOX) Expected to Post Quarterly Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) is anticipated to post its Q4 2026 results after the market closes on Tuesday, September 8th. Analysts expect Bioceres Crop Solutions to post earnings of ($0.06) per share and revenue of $79.00 million for the quarter. Interested persons can check the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Wednesday, September 16, 2026 at 12:30 PM ET.

Bioceres Crop Solutions Price Performance

Shares of BIOX opened at $0.43 on Monday. Bioceres Crop Solutions has a one year low of $0.30 and a one year high of $2.94. The stock’s fifty day moving average is $0.37 and its 200-day moving average is $0.44. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.70 and a current ratio of 0.88. The firm has a market capitalization of $27.44 million, a price-to-earnings ratio of -0.11 and a beta of 0.44.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research report on Monday, July 13th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $4.00.

Hedge Funds Weigh In On Bioceres Crop Solutions

Hedge funds have recently made changes to their positions in the business. Bank of America Corp DE boosted its holdings in Bioceres Crop Solutions by 186.7% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after buying an additional 5,339 shares in the last quarter. PDT Partners LLC lifted its position in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after acquiring an additional 10,449 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Bioceres Crop Solutions during the 3rd quarter valued at $40,000. Finally, Invesco Ltd. bought a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth $45,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.